SELLAS Life Sciences regains Nasdaq compliance for minimum market value rule

SELLAS Life Sciences Group, Inc.

Received Nasdaq letter on March 5, 2024 confirming compliance with Listing Rule 5550(b)(2).
Company maintained market value of common stock above $35M for 10 consecutive business days.
Previous non-compliance notice received on December 6, 2023; matter now closed.
Regains compliance before the June 3, 2024 deadline.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.